We overexpressed CLDN18.2 in gastric cancer cells with an overexpressed biotin tag, and after subcutaneous injection into a mouse tumor model, we used mass spectrometry to confirmed that CLDN18.2 may produce a series of tumor-promoting effects by interacting with S100A4 in the tumor microenvironment. The gene discussed is S100A4; the disease is gastric cancer.